Risk behaviours and benign prostatic hyperplasia
Daehee Kang(Seoul National University), Richard B. Hayes(New York University), R.C. Van De Vooren(University of Applied Sciences Utrecht), Donald A. Urban(University of Alabama at Birmingham), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Wen‐Yi Huang(National Institutes of Health), David Crawford(University of Colorado Health), Douglas J. Reding(Ascension), David Chia(University of California, Los Angeles)
Cited by 77
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k